logo

For the Inventor, By the Inventor

Zduńska Wola, Poland

Paulina Galka-Marciniak

This inventor holds 2 USPTO granted patents. Top assignee: Institute of Bioorganic Chemistry. Active years: 2018-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paulina Galka-Marciniak. Retrieved from https://idiyas.com/inventor/paulina-galka-marciniak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal2 out of 8 
 
Institute of Bioorganic Chemistry
 patents

Years Active: 2018-2019

Loading Chart...
2 patents (USPTO):Explore Patents
1. 10329566 - Nucleic acid molecule, expression cassette, expression vector, eukaryotic host cell, induction method of RNA interference in eukaryotic host and use of the nucleic acid molecule in therapy of diseases induced by expansion of trinucleotide CAG repeats (2019-06-25),
2. 9970004 - Nucleic acid molecule, expression cassette, expression vector, eukaryotic host cell, induction method of RNA interferencde in eukaryotic host and use of the nucleic acid molecule in therapy of diseases induced by expansion of trinucleotide CAG repeats (2018-05-15),

Title: Paulina Galka-Marciniak: A Pioneer in Genetic Therapeutics

Introduction

Paulina Galka-Marciniak is an innovative inventor hailing from Zdunska Wola, Poland. With 2 patents to her name, she is making significant contributions to the field of genetic therapeutics, particularly in treating hereditary neurological diseases.

Latest Patents

Her latest patents revolve around a groundbreaking approach to addressing ailments caused by the expansion of trinucleotide CAG-type repeats. These inventions involve a nucleic acid molecule, an expression cassette, an expression vector, and a eukaryotic host cell, alongside a method for inducing RNA interference in eukaryotic hosts. The focus of her work provides a new concept for utilizing RNA interference technology in therapies aimed at hereditary human neurological diseases.

Career Highlights

Paulina is currently affiliated with the Institute of Bioorganic Chemistry (Instytut Chemii Bioorganicznej) PAN. Her research focuses on advancing treatments that leverage cutting-edge biotechnological methods to provide hope for individuals affected by genetic disorders.

Collaborations

Throughout her career, Paulina has collaborated with esteemed colleagues, including Wlodzimierz Krzyzosiak and Marta Olejniczak. Together, they collectively enhance the research landscape of genetic therapies, contributing to the scientific community's understanding of neurological diseases.

Conclusion

In summary, Paulina Galka-Marciniak stands out as a significant figure in the field of genetic therapeutics. Her innovative patents and collaborative efforts exemplify her commitment to advancing medical science and improving the lives of those affected by hereditary conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…